Quotient Sciences – UK Headquarters – Nottingham, UK
Mere Way
Ruddington, Nottingham
NG11 6JS
T: +44 115 974 9000

Quotient Sciences – US Headquarters – Philadelphia, PA
3080 McCann Farm Drive
Garnet Valley, PA 19060
T: (800) 769-3518
W: quotientsciences.com

Linkedin: https://www.linkedin.com/company/quotient-sciences
BlueSky: https://bsky.app/profile/quotientsciences.bsky.social
Facebook: https://www.facebook.com/quotientsciences|
Instagram: https://www.instagram.com/quotient_sci
Youtube: https://www.youtube.com/@quotientsciences

Integrated drug development programs so molecules can become cures, fast

With trusted scientific insight brought to every program, Quotient Sciences is a drug development & manufacturing accelerator helping clients bring molecules to cures, fast.

With drug product development, manufacturing, and clinical testing facilities located in both the US and the UK, Quotient Sciences has worked with customers as a trusted CRDMO partner for over 35 years. Our approach to program design and delivery saves time in getting new therapies to market, without compromising quality and control of the product, data, and processes along the way.

Our comprehensive drug product (CDMO) services span a variety of dosage forms across early and late stage development, covering formulation development, clinical trial, and commercial manufacturing. e specialize in technologies for solubility enhancement, modified release, pediatric products, HPAPIs, and oral peptides.

Our clinical pharmacology (CRO) services are focused on early phase, including Phase I studies from first-in-human (FIH), single and multiple ascending dose (SAD / MAD) to regulatory and exploratory clinical studies including human ADME, TQT, DDI, and bioavailability. For all projects, the customer experience is paramount, with expert project managers leading every aspect—from project start-up through to reporting.

Quotient Sciences Translational Pharmaceutics®: Our flagship platform for drug development

We pioneered the integration of CRO and CDMO services with Translational Pharmaceutics®—a disruptive platform to enable greater efficiency in drug development. This unique approach integrates drug product manufacturing & clinical testing to reduce costs, improves decision making and accelerate development timelines by up to 12 months.

A closer look at our services:

• Formulation development – expertise in complex formulation development in areas including modified release, solubility enhancement, and pediatrics
• Clinical pharmacology – rapid study startup and recruitment through our clinical units in Miami, FL, US and Nottingham, UK, with a database of over 30,000 healthy volunteers, and capabilities to conduct. Over 1,300 Phase I studies completed with a proven track record delivering across a range of drug formulations and indications.
• Clinical trial manufacturing – a streamlined approach to drug product supply that reflects your clinical study design and timeline
• Commercial drug product manufacturing – trusted, global services for reliable commercial supply, including support for high-potency compounds and niche products with small volumes, such as pediatrics
• Data sciences – providing fast access to reliable data to improve decision making during a study
• Modeling & Simulation – PBPK modeling, FIH predictions, quality-by-design assessments, in-vitro/in-vivo correlations, bioequivalence assessments

FEATURED RESOURCES

Whitepaper: Assessing the financial impact of Translational Pharmaceutics®

Whitepaper: How to Optimize CMC and Clinical Strategies for Injectable & Oral Peptide Drugs

Whitepaper: A Road Map To Expedited Review Pathways

Whitepaper: Strategies to accelerate modified release formulations

Info Sheet: Clinical Pharmacology Services

Info Sheet: Drug Product Services

Info Sheet: Translational Pharmaceutics®